Rocket
Premium
Excel Add-In
International
Tools
Dashboard
Screener
Spinoffs
IPOs
Register
Alerts
Sign In
News + Filings
Key Docs
Charts
Transactions
Holdings
Ownership
BAYER AKTIENGESELLSCHAFT (BAYRY)
Add to portfolio
1m
|
3m
|
6m
|
1y
|
2y
|
5y
|
10y
Price:
$114.63
Metrics
OS:
Market cap:
Net cash:
$2.92
B
$∞
per share
EV:
TTM Valuation
EBITDA
EBIT
EPS
Recent News + Filings
(
All items
)
Date Filed
Type
Description
07/24/2023
4
Form 4 - Statement of changes in beneficial ownership of securities:
07/24/2023
3
Form 3 - Initial statement of beneficial ownership of securities:
02/13/2023
3
Form 3 - Initial statement of beneficial ownership of securities:
02/11/2022
SC 13G
BAYER AKTIENGESELLSCHAFT reports a 23.2% stake in Century Therapeutics, Inc.
10/15/2021
4
Bayer World Investments B.V. (Former 10% Owner) has filed a Form 4 on Pyxis Oncology, Inc.
10/07/2021
3
Bayer World Investments B.V. (10% Owner) has filed a Form 3 on Pyxis Oncology, Inc.
06/23/2021
4
BAYER AKTIENGESELLSCHAFT (10% Owner) has filed a Form 4 on Century Therapeutics, Inc.
Revenue Mix by Segment
Financial Summary
(
All financials
)
No report was found.
Rocket Data Systems, Inc. © 2019 |
Contact Us
|
Data Disclaimer
|
Terms of Use
|
Privacy
Add to: